Apricus Biosciences (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apricus Biosciences" in English language version.

refsWebsite

Global rank English rank

1^st place

low place

8,828^th place

572^nd place

436^th place

low place

2,614^th place

1,549^th place

14^th place

49^th place

47^th place

low place

accessrx.com

"NexACT Transdermal Drug Delivery Technology". Archived from the original on 25 April 2011. Retrieved 6 April 2011.

"Apricus Biosciences Inc Announces Patent Grant For Femprox In Japan". Reuters. 3 October 2010. Archived from the original on 8 September 2012. Retrieved 7 April 2011.

"Apricus Biosciences Inc Announces Patent Grant For Femprox In Japan". Reuters. 3 October 2010. Archived from the original on 8 September 2012. Retrieved 7 April 2011.

"Apricus SEC Report". SEC. Retrieved 6 April 2011.
"Form 10-Q Disclosure". www.sec.gov. SEC. Archived from the original on 28 January 2015. Retrieved 24 January 2015.

Bujdos, Brian (16 November 2010). "New Topical Erectile Dysfunction Drug Vitaros Approved in Canada; Approved Topical Drug Testim Proves Helpful for Erectile Dysfunction". Archived from the original on 13 May 2011. Retrieved 7 April 2011.
Taylor, Phil (2018-02-16). "Apricus craters as FDA rejects erectile dysfunction cream again". Fierce Biotech. Archived from the original on 2022-06-08. Retrieved 2022-06-08.
Release, Press (2014-12-22). "Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R)". Apricus Biosciences / Globenewswire. Globenewswire. Archived from the original on 2015-01-28. Retrieved 24 January 2015.
"Form 10-Q Disclosure". www.sec.gov. SEC. Archived from the original on 28 January 2015. Retrieved 24 January 2015.
"NexACT Transdermal Drug Delivery Technology". Archived from the original on 25 April 2011. Retrieved 6 April 2011.